Vasudev, Prema G and Aravinda, Subrayashastry and Ananda, Kuppanna and Veena, Shettykere Dayananda and Nagarajan, Kuppuswamy and Shamala, Narayanaswamy and Balaram, Padmanabhan (2008) Crystal Structures of a New Polymorphic Form of Gabapentin Monohydrate and the E and Z Isomers of 4-Tertiarybutylgabapentin. In: Chemical Biology & Drug Design, 73 (1). pp. 83-96.
full.pdf - Published Version
Restricted to Registered users only
Available under License Creative Commons Attribution.
Download (686Kb) | Request a copy
Gabapentin, a widely used antiepileptic drug, crystallizes in multiple polymorphic forms. A new crystal form of gabapentin monohydrate in the space group Pbca is reported and the packing arrangement compared with that of a previously reported polymorph in the space group P21/c [Ibers, J.A. (2001) Acta Crystallogr; C57:641]. Gabapentin polymorphs can also occur from a selection of one of the two distinct chair forms of the 1,1-disubstituted cyclohexane. Crystal structures of the E and Z isomers of 4-tert-butylgabapentin provide models for analyzing anticipated packing modes in the conformational isomers of gabapentin. The E isomer crystallized in the space group Pca21, while the Z isomer crystallized in the space group P21/c. The crystal structure of E-4-tert-butylgabapentin provides the only example of a structure in a non-centrosymmetric space group. Crystal structures of the hydrochloride and hydrobromide salts of 4-tert-butyl derivatives are reported. The results suggest that for gabapentin, a large 'polymorph-space' may be anticipated, in view of the multiple conformational states that are accessible to the molecule.
|Item Type:||Journal Article|
|Additional Information:||Copyright of this article belongs to Blackwell Publishing.|
|Keywords:||1;1-disubstituted cyclohexane;crystal structures; gabapentin;polymorphs;tert-butylgabapentin.|
|Department/Centre:||Division of Biological Sciences > Molecular Biophysics Unit
Division of Physical & Mathematical Sciences > Physics
|Date Deposited:||17 Aug 2009 09:39|
|Last Modified:||19 Sep 2010 05:00|
Actions (login required)